KMT2A and leukemia: Structural alterations of the mixed lineage leukemia gene (KMT2A also known as MLL) by chromosomal translocations cause malignant leukemia that often associates with poor prognosis despite the current intensive treatment regimens (Tamai and Inokuchi, 2010).